Hydrea 500 Deva

£138.00

Hydrea 500 Deva is a pharmaceutical-grade hydroxyurea preparation available in 500mg capsules for in-vitro laboratory research applications.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Hydrea 500 Deva
Hydrea 500 Deva
£138.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Hydroxyurea Research Overview

Hydrea 500 Deva is a pharmaceutical preparation containing hydroxyurea, a well-established research compound with decades of clinical study history. Hydroxyurea is an antimetabolite that has been extensively investigated in laboratory settings for its effects on cellular processes and DNA synthesis pathways. Research facilities examining cell cycle dynamics, ribonucleotide reductase inhibition, and cellular proliferation mechanisms often utilise this compound in controlled laboratory environments. Each capsule contains 500mg of active hydroxyurea for precise dosing in research protocols.

Laboratory investigators studying cellular biology can access comprehensive research compounds through Stroid UK Shop, which maintains extensive quality documentation for all pharmaceutical preparations. The facility also stocks complementary research materials including selective androgen receptor modulators and research peptides for comprehensive laboratory studies.

Laboratory Research Applications

Hydroxyurea serves as a valuable research tool in multiple laboratory applications. Cell culture researchers investigate its mechanisms of action on ribonucleotide reductase, the enzyme responsible for converting ribonucleotides to deoxyribonucleotides essential for DNA synthesis. This inhibition leads to S-phase arrest in cell cycle studies, making it particularly useful for synchronisation experiments. Researchers examine its effects on haemoglobin switching in sickle cell disease models, where it increases fetal haemoglobin production through gamma-globin gene activation.

Oncology research laboratories study hydroxyurea’s role as a radiosensitiser, enhancing the effects of radiation therapy in experimental models. The compound’s ability to induce DNA damage and cell cycle checkpoint activation makes it valuable for studying cellular repair mechanisms and apoptotic pathways. Dermatological research applications also utilise hydroxyurea preparations for investigating cellular turnover in skin models.

Product Specifications

Hydrea 500 Deva Technical Specifications
Parameter Value
Active Compound Hydroxyurea
Strength 500mg per capsule
CAS Number 127-07-1
Molecular Formula CH₄N₂O₂
Molecular Weight 76.05 g/mol
Storage Temperature Room temperature, dry conditions
Shelf Life As per manufacturer specifications

Compliance and Research Use

Hydrea 500 Deva is supplied exclusively for in-vitro research purposes and laboratory investigations. This pharmaceutical preparation is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must maintain appropriate safety protocols and disposal procedures when handling this compound. All research activities should comply with institutional guidelines and relevant regulatory frameworks governing laboratory research compounds.

Related